Dr. Dennis Adeegbe obtained his Ph.D. in Immunology at the University of Miami, where his research focused on immune tolerance in the context of autoimmunity and transplantation tolerance. Supported by the Japanese Society for the Promotion of Science, he completed a postdoctoral fellowship in the lab of Shimon Sakaguchi, from where his research in Immuno-Oncology began. He subsequently joined the Dana-Farber Cancer Institute as a post-doctoral research fellow where his training and research experiences involved translational studies in lung cancer under the supervision of Dr. Kwok-Kin Wong. Dr. Adeegbe is currently a member of the faculty in the Department of Immunology within the H. Lee Moffitt Cancer Center, where he is directing an independent research team focused on tumor immunology and immunotherapy, while contributing to collaborative studies aimed at finding cures for cancer.
Catherine Reyes is a Grants Administrator Associate in the Basic Science Department at Moffitt Cancer Center. She is an Assistant to Dennis Adeegbe, an Assistant Member of the Department of Immunology. She is also an Assistant to Jiandong Chen, a Senior Member of the Department of Molecular Oncology, Gary Reuther, an Associate Member of the Department of Molecular Oncology, and Paulo Rodriguez, an Associate Member of the Department of Immunology.
Andrew Schultz completed a B.S. in Microbiology & Cell Science with a minor in Music Performance and a M.P.H. in Epidemiology from the University of Florida. Andrew is currently enrolled in the M.P.S. – Data Analytics program at the World Campus of the Pennsylvania State University. Andrew has previous experience working with the vaccinia virus, the first vaccine that was used to eliminate smallpox, and multiple pathogenic bacteria, with a few implicated in the development of cancer. Also, he has experience examining the interconnectedness of the immune system, genetics and potential confounding variables of the peripheral blood and tissues from human organ donors in the context of autoimmunity (type 1 diabetes). Andrew plans on applying his past experiences to systematically contribute to the advancement of cancer research through creativity and collaboration.
Rachel Thurn is a Research Trainee in Dr. Adeegbe’s Immunology Research Laboratory at Moffitt Cancer Center. She is currently a third year undergraduate student enrolled at USF, pursing a major in Biomedical sciences and a minor in Psychology. She is hoping to continue her studies after graduation in the field of Pharmaceuticals.
Julieta Abraham-Miranda is a Postdoctoral Fellow in Dr. Adeegbe’s (Immunology Department) and Dr. Yamoah’s (Cancer Epidemiology Department) laboratories at Moffitt Cancer Center. She obtained her Pharmaceutical degree in Argentina at the National University of Cordoba. She completed her PhD in the Pharmaceutical Sciences Department at the National University of Cordoba, Argentina studying how polymorphisms impacts the pharmacokinetics of drugs used in the clinic. During her PhD Julieta gained experience in the evaluation and optimization of biopharmaceutical properties of pharmaceutical compounds. She mainly focuses its attention on improving the oral bioavailability of different drugs modifying parameters such as solubility, dissolution, permeability and/or stability of the drugs. Julieta plans to apply her knowledge in the pharmaceutical area and combine it with the knowledge of the Adeegbe’s team in immunology and with the knowledge of Yamoah’s team in prostate cancer in order to find and/or optimize treatments that could help patients with cancer.
Arup Bag is a Postdoctoral Fellow in Dr. Adeegbe’s (Immunology Department) laboratory at Moffitt Cancer Center. He completed his PhD in Biochemistry from the University of Calcutta, India studying “Proteomic and Glycomic Approaches in Understanding of Disease Biology” of Glioblastoma multiforme and Visceral Leishmaniasis. During his PhD, Arup gained experience in cancer biology and various types of proteomics approaches used in biological research. After completion of his PhD, he moved to University of Nebraska Medical Center, NE, USA as a Postdoctoral Research Fellow studying the “Manifestation of differential expression and post-translational modification of Neuropilin-2 (NRP2) in different types of myeloid cells and its biological implications” in pancreatic cancer progression and prostate cancer bone metastasis. Then he moved to Mayo Clinic, Arizona, USA to continue his second Postdoctoral Fellowship in understanding the “Role of Unsaturated fatty acid in Pancreatitis Outcome”. He wants to apply his knowledge and experience of proteomics, biochemistry, cancer biology, cell biology and microscopy with combination of knowledge of the Adeegbe’s team in immunology to develop improved, potential and optimize immunotherapeutic treatment that will be helpful for cancer patient.